EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Synergistic Dual‐Atom Sites Nanozyme Augments Immunogenic Cell Death for Efficient Immunotherapy

Shipeng Ning, Zeyuan Zhang, Yujing Ren, Yaxin Hou, Dan Li, Jingqi Chen, Yujie Zhai, Kelong Fan iD, Weiqing Zhang

Advanced Science · 2025-02 · 12 (7)

DOI: 10.1002/advs.202414734 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 24.12.2024. Verfasst von Shipeng Ning und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, The Second Affiliated Hospital of Guangxi Medical University, Nanning, 530000, China. Hauptthemen laut MEDLINE: Immunotherapy, Immunogenic Cell Death, Neoplasms. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangxi Provincial Natural Science Foundation, Advanced Innovation Teams and Xinghu Scholars Program of Guangxi Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inducing immunogenic cell death (ICD) is a promising approach to elicit enduring antitumor immune responses. Hence, extensive efforts are being made to develop ICD inducers. Herein, a cascaded dual‐atom nanozyme with Fe and Cu sites (FeCu‐DA) as an efficient ICD inducer is presented. The Fe and Cu dual‐atom sites synergistically enhance peroxidase (POD) and catalase activities, effectively converting intratumoral hydrogen peroxide (H 2 O 2 ) to hydroxyl radicals (·OH) and oxygen (O 2 ). Moreover, FeCu‐DA exhibits superior glutathione‐oxidase (GSH‐OXD) activity, catalyzing GSH oxidation to generate H 2 O 2 , enabling cascaded catalysis for sustainable ∙OH generation and reducing reactive oxygen species (ROS) resistance by consuming GSH. Steady–state kinetic analysis and density functional theory calculations indicate that FeCu‐DA exhibits a higher catalytic rate and efficiency than Fe single‐atom nanozymes (Fe‐SA) because of its stronger interactions with H 2 O 2 . Its POD activity is 948.05 U mg −1 , which is 2.8‐fold greater than that of Fe‐SA. Furthermore, FeCu‐DA exhibits impressive photothermal effects and photothermal‐enhanced cascaded catalysis kinetics for ROS generation, thereby inducing potent ICD. Combined with anti‐PD‐L1 antibody (αPD‐L1) blockade, FeCu‐DA shows synergistic enhancement in treatment under near‐infrared irradiation. This study provides insights for designing efficient dual‐atom nanozymes and demonstrates their potential in ICD‐induced cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyImmunogenic Cell DeathNeoplasmsMiceAnimalsHumansCopperHydrogen PeroxideIronReactive Oxygen SpeciesCell Line, Tumor

Stichwörter der Autor:innen

cancer immunotherapycascaded catalysisdual‐atom nanozymeimmunogenic cell deathphotothermal therapy

Substanzen

CopperHydrogen PeroxideIronReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Breast Surgery, The Second Affiliated Hospital of Guangxi Medical University, Nanning, 530000, China.
  • Department of Research, Guangxi Medical University Cancer Hospital, Guangxi Medical University, Nanning, 530021, China.
  • University Engineering Research Center of Oncolytic & Nanosystem Development, Guangxi, 530021, China.
  • West China School of Medicine, Sichuan University, Chengdu, 610041, China.
  • Interdisciplinary Research Center of Biology & Catalysis, School of Life Sciences, Northwestern Polytechnical University, Xi'an, 710072, China.
  • CAS Engineering Laboratory for Nanozyme, Key Laboratory of Biomacromolecules (CAS), CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.

ORCID-Profile: Kelong Fan

Förderung

  • National Natural Science Foundation of China
  • Guangxi Provincial Natural Science Foundation
  • Advanced Innovation Teams and Xinghu Scholars Program of Guangxi Medical University
  • Guangxi Medical University Cancer Hospital

Zitieren

APA

Ning, S., Zhang, Z., Ren, Y., Hou, Y., Li, D., Chen, J., Zhai, Y., Fan, K., & Zhang, W. (2025). A Synergistic Dual‐Atom Sites Nanozyme Augments Immunogenic Cell Death for Efficient Immunotherapy. Advanced Science, 12(7). https://doi.org/10.1002/advs.202414734

Vancouver

Ning S, Zhang Z, Ren Y, Hou Y, Li D, Chen J, et al. A Synergistic Dual‐Atom Sites Nanozyme Augments Immunogenic Cell Death for Efficient Immunotherapy. Advanced Science. 2025;12(7). doi:10.1002/advs.202414734

BibTeX
@article{Ning2025,
  author = {Ning, Shipeng and Zhang, Zeyuan and Ren, Yujing and Hou, Yaxin and Li, Dan and Chen, Jingqi and Zhai, Yujie and Fan, Kelong and Zhang, Weiqing},
  title = {A Synergistic Dual‐Atom Sites Nanozyme Augments Immunogenic Cell Death for Efficient Immunotherapy},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {7},
  doi = {10.1002/advs.202414734}
}
Kostenlos starten →